1 Study Coverage 1.1 Surgical Hemostatic Agents Product Introduction 1.2 Market by Type 1.2.1 Global Surgical Hemostatic Agents Market Size Growth Rate by Type 1.2.2 Gelation Hemostats 1.2.3 Combination Hemostats 1.2.4 Others 1.3 Market by Application 1.3.1 Global Surgical Hemostatic Agents Market Size Growth Rate by Application 1.3.2 Hospitals 1.3.3 Surgical Centers 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Surgical Hemostatic Agents Market Size, Estimates and Forecasts 2.1.1 Global Surgical Hemostatic Agents Revenue 2016-2027 2.1.2 Global Surgical Hemostatic Agents Sales 2016-2027 2.2 Global Surgical Hemostatic Agents, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Surgical Hemostatic Agents Historical Market Size by Region (2016-2021) 2.3.1 Global Surgical Hemostatic Agents Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Surgical Hemostatic Agents Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Surgical Hemostatic Agents Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Surgical Hemostatic Agents Sales Forecast by Region (2022-2027) 2.4.2 Global Surgical Hemostatic Agents Revenue Forecast by Region (2022-2027) 3 Global Surgical Hemostatic Agents Competitor Landscape by Players 3.1 Global Top Surgical Hemostatic Agents Manufacturers by Sales 3.1.1 Global Surgical Hemostatic Agents Sales by Manufacturer (2016-2021) 3.1.2 Global Surgical Hemostatic Agents Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Surgical Hemostatic Agents Manufacturers by Revenue 3.2.1 Key Surgical Hemostatic Agents Manufacturers Covered: Ranking by Revenue 3.2.2 Global Surgical Hemostatic Agents Revenue by Manufacturers (2016-2021) 3.2.3 Global Surgical Hemostatic Agents Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Surgical Hemostatic Agents Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Surgical Hemostatic Agents Revenue in 2020 3.2.6 Global Surgical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Surgical Hemostatic Agents Price by Manufacturers 3.4 Global Surgical Hemostatic Agents Manufacturing Base Distribution, Product Types 3.4.1 Surgical Hemostatic Agents Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Surgical Hemostatic Agents Product Type 3.4.3 Date of International Manufacturers Enter into Surgical Hemostatic Agents Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Surgical Hemostatic Agents Market Size by Type (2016-2021) 4.1.1 Global Surgical Hemostatic Agents Sales by Type (2016-2021) 4.1.2 Global Surgical Hemostatic Agents Revenue by Type (2016-2021) 4.1.3 Surgical Hemostatic Agents Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Surgical Hemostatic Agents Market Size Forecast by Type (2022-2027) 4.2.1 Global Surgical Hemostatic Agents Sales Forecast by Type (2022-2027) 4.2.2 Global Surgical Hemostatic Agents Revenue Forecast by Type (2022-2027) 4.2.3 Surgical Hemostatic Agents Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Surgical Hemostatic Agents Market Size by Application (2016-2021) 5.1.1 Global Surgical Hemostatic Agents Sales by Application (2016-2021) 5.1.2 Global Surgical Hemostatic Agents Revenue by Application (2016-2021) 5.1.3 Surgical Hemostatic Agents Price by Application (2016-2021) 5.2 Surgical Hemostatic Agents Market Size Forecast by Application (2022-2027) 5.2.1 Global Surgical Hemostatic Agents Sales Forecast by Application (2022-2027) 5.2.2 Global Surgical Hemostatic Agents Revenue Forecast by Application (2022-2027) 5.2.3 Global Surgical Hemostatic Agents Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Surgical Hemostatic Agents Market Size YoY Growth 2016-2027 6.1.1 China Surgical Hemostatic Agents Sales YoY Growth 2016-2027 6.1.2 China Surgical Hemostatic Agents Revenue YoY Growth 2016-2027 6.1.3 China Surgical Hemostatic Agents Market Share in Global Market 2016-2027 6.2 China Surgical Hemostatic Agents Market Size by Players (International and Local Players) 6.2.1 China Top Surgical Hemostatic Agents Players by Sales (2016-2021) 6.2.2 China Top Surgical Hemostatic Agents Players by Revenue (2016-2021) 6.3 China Surgical Hemostatic Agents Historic Market Review by Type (2016-2021) 6.3.1 China Surgical Hemostatic Agents Sales Market Share by Type (2016-2021) 6.3.2 China Surgical Hemostatic Agents Revenue Market Share by Type (2016-2021) 6.3.3 China Surgical Hemostatic Agents Price by Type (2016-2021) 6.4 China Surgical Hemostatic Agents Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Surgical Hemostatic Agents Sales Forecast by Type (2022-2027) 6.4.2 China Surgical Hemostatic Agents Revenue Forecast by Type (2022-2027) 6.4.3 China Surgical Hemostatic Agents Price Forecast by Type (2022-2027) 6.5 China Surgical Hemostatic Agents Historic Market Review by Application (2016-2021) 6.5.1 China Surgical Hemostatic Agents Sales Market Share by Application (2016-2021) 6.5.2 China Surgical Hemostatic Agents Revenue Market Share by Application (2016-2021) 6.5.3 China Surgical Hemostatic Agents Price by Application (2016-2021) 6.6 China Surgical Hemostatic Agents Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Surgical Hemostatic Agents Sales Forecast by Application (2022-2027) 6.6.2 China Surgical Hemostatic Agents Revenue Forecast by Application (2022-2027) 6.6.3 China Surgical Hemostatic Agents Price Forecast by Application (2022-2027) 7 North America 7.1 North America Surgical Hemostatic Agents Market Size YoY Growth 2016-2027 7.2 North America Surgical Hemostatic Agents Market Facts & Figures by Country 7.2.1 North America Surgical Hemostatic Agents Sales by Country (2016-2021) 7.2.2 North America Surgical Hemostatic Agents Revenue by Country (2016-2021) 7.2.3 United States 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Surgical Hemostatic Agents Market Size YoY Growth 2016-2027 8.2 Asia Pacific Surgical Hemostatic Agents Market Facts & Figures by Region 8.2.1 Asia Pacific Surgical Hemostatic Agents Sales by Region (2016-2021) 8.2.2 Asia Pacific Surgical Hemostatic Agents Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 9 Europe 9.1 Europe Surgical Hemostatic Agents Market Size YoY Growth 2016-2027 9.2 Europe Surgical Hemostatic Agents Market Facts & Figures by Country 9.2.1 Europe Surgical Hemostatic Agents Sales by Country (2016-2021) 9.2.2 Europe Surgical Hemostatic Agents Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Surgical Hemostatic Agents Market Size YoY Growth 2016-2027 10.2 Latin America Surgical Hemostatic Agents Market Facts & Figures by Country 10.2.1 Latin America Surgical Hemostatic Agents Sales by Country (2016-2021) 10.2.2 Latin America Surgical Hemostatic Agents Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 10.2.6 Colombia 11 Middle East and Africa 11.1 Middle East and Africa Surgical Hemostatic Agents Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Surgical Hemostatic Agents Market Facts & Figures by Country 11.2.1 Middle East and Africa Surgical Hemostatic Agents Sales by Country (2016-2021) 11.2.2 Middle East and Africa Surgical Hemostatic Agents Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 J&J 12.1.1 J&J Corporation Information 12.1.2 J&J Description and Business Overview 12.1.3 J&J Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021) 12.1.4 J&J Surgical Hemostatic Agents Products Offered 12.1.5 J&J Recent Development 12.2 Baxter 12.2.1 Baxter Corporation Information 12.2.2 Baxter Description and Business Overview 12.2.3 Baxter Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Baxter Surgical Hemostatic Agents Products Offered 12.2.5 Baxter Recent Development 12.3 BD 12.3.1 BD Corporation Information 12.3.2 BD Description and Business Overview 12.3.3 BD Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021) 12.3.4 BD Surgical Hemostatic Agents Products Offered 12.3.5 BD Recent Development 12.4 Gelita 12.4.1 Gelita Corporation Information 12.4.2 Gelita Description and Business Overview 12.4.3 Gelita Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Gelita Surgical Hemostatic Agents Products Offered 12.4.5 Gelita Recent Development 12.5 Pfizer 12.5.1 Pfizer Corporation Information 12.5.2 Pfizer Description and Business Overview 12.5.3 Pfizer Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Pfizer Surgical Hemostatic Agents Products Offered 12.5.5 Pfizer Recent Development 12.6 B Braun 12.6.1 B Braun Corporation Information 12.6.2 B Braun Description and Business Overview 12.6.3 B Braun Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021) 12.6.4 B Braun Surgical Hemostatic Agents Products Offered 12.6.5 B Braun Recent Development 12.7 CSL Behring 12.7.1 CSL Behring Corporation Information 12.7.2 CSL Behring Description and Business Overview 12.7.3 CSL Behring Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021) 12.7.4 CSL Behring Surgical Hemostatic Agents Products Offered 12.7.5 CSL Behring Recent Development 12.8 Ferrosan Medical Devices 12.8.1 Ferrosan Medical Devices Corporation Information 12.8.2 Ferrosan Medical Devices Description and Business Overview 12.8.3 Ferrosan Medical Devices Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Ferrosan Medical Devices Surgical Hemostatic Agents Products Offered 12.8.5 Ferrosan Medical Devices Recent Development 12.9 Advance Medical Solution 12.9.1 Advance Medical Solution Corporation Information 12.9.2 Advance Medical Solution Description and Business Overview 12.9.3 Advance Medical Solution Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Advance Medical Solution Surgical Hemostatic Agents Products Offered 12.9.5 Advance Medical Solution Recent Development 12.10 Medtronic 12.10.1 Medtronic Corporation Information 12.10.2 Medtronic Description and Business Overview 12.10.3 Medtronic Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Medtronic Surgical Hemostatic Agents Products Offered 12.10.5 Medtronic Recent Development 12.11 J&J 12.11.1 J&J Corporation Information 12.11.2 J&J Description and Business Overview 12.11.3 J&J Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021) 12.11.4 J&J Surgical Hemostatic Agents Products Offered 12.11.5 J&J Recent Development 12.12 Marine Polymer 12.12.1 Marine Polymer Corporation Information 12.12.2 Marine Polymer Description and Business Overview 12.12.3 Marine Polymer Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Marine Polymer Products Offered 12.12.5 Marine Polymer Recent Development 12.13 Equimedical 12.13.1 Equimedical Corporation Information 12.13.2 Equimedical Description and Business Overview 12.13.3 Equimedical Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Equimedical Products Offered 12.13.5 Equimedical Recent Development 12.14 CryoLife 12.14.1 CryoLife Corporation Information 12.14.2 CryoLife Description and Business Overview 12.14.3 CryoLife Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2016-2021) 12.14.4 CryoLife Products Offered 12.14.5 CryoLife Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Surgical Hemostatic Agents Industry Trends 13.2 Surgical Hemostatic Agents Market Drivers 13.3 Surgical Hemostatic Agents Market Challenges 13.4 Surgical Hemostatic Agents Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Surgical Hemostatic Agents Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Surgical Hemostatic Agents Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Gelation Hemostats Table 3. Major Manufacturers of Combination Hemostats Table 4. Major Manufacturers of Others Table 5. Global Surgical Hemostatic Agents Market Size Growth Rate by Application (2021-2027) & (K Units) Table 6. Global Surgical Hemostatic Agents Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Surgical Hemostatic Agents Sales by Regions (2016-2021) & (K Units) Table 8. Global Surgical Hemostatic Agents Sales Market Share by Regions (2016-2021) Table 9. Global Surgical Hemostatic Agents Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Surgical Hemostatic Agents Sales Forecast by Region (2022-2027) & (K Units) Table 11. Global Surgical Hemostatic Agents Sales Market Share Forecast by Region (2022-2027) Table 12. Global Surgical Hemostatic Agents Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Surgical Hemostatic Agents Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Surgical Hemostatic Agents Sales by Manufacturers (2016-2021) (K Units) Table 15. Global Surgical Hemostatic Agents Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Surgical Hemostatic Agents Manufacturers by Revenue (US$ Million) in 2020 Table 17. Surgical Hemostatic Agents Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Surgical Hemostatic Agents Revenue Share by Manufacturers (2016-2021) Table 19. Global Surgical Hemostatic Agents Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Surgical Hemostatic Agents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Surgical Hemostatic Agents as of 2020) Table 21. Key Manufacturers Surgical Hemostatic Agents Price (2016-2021) (US$/Unit) Table 22. Surgical Hemostatic Agents Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Surgical Hemostatic Agents Product Type Table 24. Date of International Manufacturers Enter into Surgical Hemostatic Agents Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Surgical Hemostatic Agents Sales by Type (2016-2021) (K Units) Table 27. Global Surgical Hemostatic Agents Sales Share by Type (2016-2021) Table 28. Global Surgical Hemostatic Agents Revenue by Type (2016-2021) (US$ Million) Table 29. Global Surgical Hemostatic Agents Revenue Share by Type (2016-2021) Table 30. Surgical Hemostatic Agents Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 31. Global Surgical Hemostatic Agents Sales Forecast by Type (2022-2027) & (K Units) Table 32. Global Surgical Hemostatic Agents Sales Market Share Forecast by Type (2022-2027) Table 33. Global Surgical Hemostatic Agents Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Surgical Hemostatic Agents Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Surgical Hemostatic Agents Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 36. Global Surgical Hemostatic Agents Sales by Application (2016-2021) (K Units) Table 37. Global Surgical Hemostatic Agents Sales Share by Application (2016-2021) Table 38. Global Surgical Hemostatic Agents Revenue by Application (2016-2021) (US$ Million) Table 39. Global Surgical Hemostatic Agents Revenue Share by Application (2016-2021) Table 40. Surgical Hemostatic Agents Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 41. Global Surgical Hemostatic Agents Sales Forecast by Application (2022-2027) & (K Units) Table 42. Global Surgical Hemostatic Agents Sales Market Share Forecast by Application (2022-2027) Table 43. Global Surgical Hemostatic Agents Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Surgical Hemostatic Agents Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Surgical Hemostatic Agents Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 46. China Surgical Hemostatic Agents Sales (K Units) of Key Companies (2016-2021) Table 47. China Surgical Hemostatic Agents Sales Share by Company (2016-2021) Table 48. China Surgical Hemostatic Agents Revenue (US$ Million) by Company (2016-2021) Table 49. China Surgical Hemostatic Agents Revenue Share by Company (2016-2021) Table 50. China Surgical Hemostatic Agents Sales (K Units) by Type (2016-2021) Table 51. China Surgical Hemostatic Agents Sales Share by Type (2016-2021) Table 52. China Surgical Hemostatic Agents Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. China Surgical Hemostatic Agents Price (US$/Unit) by Type (2016-2021) Table 54. China Surgical Hemostatic Agents Sales (K Units) by Type (2022-2027) Table 55. China Surgical Hemostatic Agents Sales Share by Type (2022-2027) Table 56. China Surgical Hemostatic Agents Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. China Surgical Hemostatic Agents Revenue Share by Type (2022-2027) Table 58. China Surgical Hemostatic Agents Price (US$/Unit) by Type (2022-2027) Table 59. China Surgical Hemostatic Agents Sales (K Units) by Application (2016-2021) Table 60. China Surgical Hemostatic Agents Sales Share by Application (2016-2021) Table 61. China Surgical Hemostatic Agents Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. China Surgical Hemostatic Agents Price (US$/Unit) by Application (2016-2021) Table 63. China Surgical Hemostatic Agents Sales (K Units) by Application (2022-2027) Table 64. China Surgical Hemostatic Agents Sales Share by Application (2022-2027) Table 65. China Surgical Hemostatic Agents Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. China Surgical Hemostatic Agents Revenue Share by Application (2022-2027) Table 67. China Surgical Hemostatic Agents Price (US$/Unit) by Application (2022-2027) Table 68. North America Surgical Hemostatic Agents Sales by Country (2016-2021) & (K Units) Table 69. North America Surgical Hemostatic Agents Sales Market Share by Country (2016-2021) Table 70. North America Surgical Hemostatic Agents Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Surgical Hemostatic Agents Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Surgical Hemostatic Agents Sales by Region (2016-2021) & (K Units) Table 73. Asia Pacific Surgical Hemostatic Agents Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Surgical Hemostatic Agents Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Surgical Hemostatic Agents Revenue Market Share by Region (2016-2021) Table 76. Europe Surgical Hemostatic Agents Sales by Country (2016-2021) & (K Units) Table 77. Europe Surgical Hemostatic Agents Sales Market Share by Country (2016-2021) Table 78. Europe Surgical Hemostatic Agents Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Surgical Hemostatic Agents Revenue Market Share by Country (2016-2021) Table 80. Latin America Surgical Hemostatic Agents Sales by Country (2016-2021) & (K Units) Table 81. Latin America Surgical Hemostatic Agents Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Surgical Hemostatic Agents Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Surgical Hemostatic Agents Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Surgical Hemostatic Agents Sales by Country (2016-2021) & (K Units) Table 85. Middle East and Africa Surgical Hemostatic Agents Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Surgical Hemostatic Agents Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Surgical Hemostatic Agents Revenue Market Share by Country (2016-2021) Table 88. J&J Corporation Information Table 89. J&J Description and Business Overview Table 90. J&J Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. J&J Surgical Hemostatic Agents Product Table 92. J&J Recent Development Table 93. Baxter Corporation Information Table 94. Baxter Description and Business Overview Table 95. Baxter Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. Baxter Product Table 97. Baxter Recent Development Table 98. BD Corporation Information Table 99. BD Description and Business Overview Table 100. BD Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. BD Product Table 102. BD Recent Development Table 103. Gelita Corporation Information Table 104. Gelita Description and Business Overview Table 105. Gelita Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. Gelita Product Table 107. Gelita Recent Development Table 108. Pfizer Corporation Information Table 109. Pfizer Description and Business Overview Table 110. Pfizer Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 111. Pfizer Product Table 112. Pfizer Recent Development Table 113. B Braun Corporation Information Table 114. B Braun Description and Business Overview Table 115. B Braun Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 116. B Braun Product Table 117. B Braun Recent Development Table 118. CSL Behring Corporation Information Table 119. CSL Behring Description and Business Overview Table 120. CSL Behring Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 121. CSL Behring Product Table 122. CSL Behring Recent Development Table 123. Ferrosan Medical Devices Corporation Information Table 124. Ferrosan Medical Devices Description and Business Overview Table 125. Ferrosan Medical Devices Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 126. Ferrosan Medical Devices Product Table 127. Ferrosan Medical Devices Recent Development Table 128. Advance Medical Solution Corporation Information Table 129. Advance Medical Solution Description and Business Overview Table 130. Advance Medical Solution Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 131. Advance Medical Solution Product Table 132. Advance Medical Solution Recent Development Table 133. Medtronic Corporation Information Table 134. Medtronic Description and Business Overview Table 135. Medtronic Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 136. Medtronic Product Table 137. Medtronic Recent Development Table 138. Z-Medica Corporation Information Table 139. Z-Medica Description and Business Overview Table 140. Z-Medica Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 141. Z-Medica Product Table 142. Z-Medica Recent Development Table 143. Marine Polymer Corporation Information Table 144. Marine Polymer Description and Business Overview Table 145. Marine Polymer Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 146. Marine Polymer Product Table 147. Marine Polymer Recent Development Table 148. Equimedical Corporation Information Table 149. Equimedical Description and Business Overview Table 150. Equimedical Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 151. Equimedical Product Table 152. Equimedical Recent Development Table 153. CryoLife Corporation Information Table 154. CryoLife Description and Business Overview Table 155. CryoLife Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 156. CryoLife Product Table 157. CryoLife Recent Development Table 158. Surgical Hemostatic Agents Market Trends Table 159. Surgical Hemostatic Agents Market Drivers Table 160. Surgical Hemostatic Agents Market Challenges Table 161. Surgical Hemostatic Agents Market Restraints Table 162. Surgical Hemostatic Agents Customers List Table 163. Surgical Hemostatic Agents Distributors List Table 164. Research Programs/Design for This Report Table 165. Key Data Information from Secondary Sources Table 166. Key Data Information from Primary Sources List of Figures Figure 1. Surgical Hemostatic Agents Product Picture Figure 2. Global Surgical Hemostatic Agents Sales Market Share by Type in 2020 & 2027 Figure 3. Gelation Hemostats Product Picture Figure 4. Combination Hemostats Product Picture Figure 5. Others Product Picture Figure 6. Global Surgical Hemostatic Agents Sales Market Share by Application in 2020 & 2027 Figure 7. Hospitals Figure 8. Surgical Centers Figure 9. Other Figure 10. Surgical Hemostatic Agents Report Years Considered Figure 11. Global Surgical Hemostatic Agents Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Surgical Hemostatic Agents Market Size 2016-2027 (US$ Million) Figure 13. Global Surgical Hemostatic Agents Sales 2016-2027 (K Units) Figure 14. Global Surgical Hemostatic Agents Market Size Market Share by Region: 2021 Versus 2027 Figure 15. Global Surgical Hemostatic Agents Sales Market Share by Region (2016-2021) Figure 16. Global Surgical Hemostatic Agents Sales Market Share by Region in 2020 Figure 17. Global Surgical Hemostatic Agents Revenue Market Share by Region (2016-2021) Figure 18. Global Surgical Hemostatic Agents Revenue Market Share by Region in 2020 Figure 19. Global Surgical Hemostatic Agents Sales Share by Manufacturer in 2020 Figure 20. The Top 10 and 5 Players Market Share by Surgical Hemostatic Agents Revenue in 2020 Figure 21. Surgical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 22. Global Surgical Hemostatic Agents Sales Market Share by Type (2016-2021) Figure 23. Global Surgical Hemostatic Agents Sales Market Share by Type in 2020 Figure 24. Global Surgical Hemostatic Agents Revenue Market Share by Type (2016-2021) Figure 25. Global Surgical Hemostatic Agents Revenue Market Share by Type in 2020 Figure 26. Global Surgical Hemostatic Agents Sales Market Share by Application (2016-2021) Figure 27. Global Surgical Hemostatic Agents Sales Market Share by Application in 2020 Figure 28. Global Surgical Hemostatic Agents Revenue Market Share by Application (2016-2021) Figure 29. Global Surgical Hemostatic Agents Revenue Market Share by Application in 2020 Figure 30. China Surgical Hemostatic Agents Sales Growth Rate 2016-2027 (K Units) Figure 31. China Surgical Hemostatic Agents Revenue Growth Rate 2016-2027 (US$ Million) Figure 32. China Surgical Hemostatic Agents Market Share in Global Market 2016-2027 Figure 33. China 5 and 10 Largest Surgical Hemostatic Agents Players Market Share by Revenue in Surgical Hemostatic Agents in 2020 Figure 34. China Surgical Hemostatic Agents Revenue Share by Type (2016-2021) Figure 35. China Surgical Hemostatic Agents Revenue Growth Rate by Type in 2016 & 2020 Figure 36. China Surgical Hemostatic Agents Revenue Share by Application (2016-2021) Figure 37. China Surgical Hemostatic Agents Revenue Growth Rate by Application in 2016 & 2020 Figure 38. North America Surgical Hemostatic Agents Sales Growth Rate 2016-2021 (K Units) Figure 39. North America Surgical Hemostatic Agents Revenue Growth Rate 2016-2021 (US$ Million) Figure 40. North America Surgical Hemostatic Agents Sales Market Share by Country in 2020 Figure 41. North America Surgical Hemostatic Agents Revenue Market Share by Country in 2020 Figure 42. United States Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 43. United States Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Canada Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 45. Canada Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Europe Surgical Hemostatic Agents Sales Growth Rate 2016-2021 (K Units) Figure 47. Europe Surgical Hemostatic Agents Revenue Growth Rate 2016-2021 (US$ Million) Figure 48. Europe Surgical Hemostatic Agents Sales Market Share by Country in 2020 Figure 49. Europe Surgical Hemostatic Agents Revenue Market Share by Country in 2020 Figure 50. Germany Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 51. Germany Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. France Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 53. France Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. U.K. Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 55. U.K. Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Italy Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 57. Italy Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Russia Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 59. Russia Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Asia Pacific Surgical Hemostatic Agents Sales Growth Rate 2016-2021 (K Units) Figure 61. Asia Pacific Surgical Hemostatic Agents Revenue Growth Rate 2016-2021 (US$ Million) Figure 62. Asia Pacific Surgical Hemostatic Agents Sales Market Share by Region in 2020 Figure 63. Asia Pacific Surgical Hemostatic Agents Revenue Market Share by Region in 2020 Figure 64. China Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 65. China Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. Japan Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 67. Japan Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. South Korea Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 69. South Korea Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. India Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 71. India Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Australia Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 73. Australia Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. China Taiwan Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 75. China Taiwan Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Indonesia Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 77. Indonesia Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Thailand Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 79. Thailand Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Malaysia Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 81. Malaysia Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Latin America Surgical Hemostatic Agents Sales Growth Rate 2016-2021 (K Units) Figure 83. Latin America Surgical Hemostatic Agents Revenue Growth Rate 2016-2021 (US$ Million) Figure 84. Latin America Surgical Hemostatic Agents Sales Market Share by Country in 2020 Figure 85. Latin America Surgical Hemostatic Agents Revenue Market Share by Country in 2020 Figure 86. Mexico Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 87. Mexico Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 88. Brazil Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 89. Brazil Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 90. Argentina Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 91. Argentina Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Colombia Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 93. Colombia Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Middle East and Africa Surgical Hemostatic Agents Sales Growth Rate 2016-2021 (K Units) Figure 95. Middle East and Africa Surgical Hemostatic Agents Revenue Growth Rate 2016-2021 (US$ Million) Figure 96. Middle East and Africa Surgical Hemostatic Agents Sales Market Share by Country in 2020 Figure 97. Middle East and Africa Surgical Hemostatic Agents Revenue Market Share by Country in 2020 Figure 98. Turkey Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 99. Turkey Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 100. Saudi Arabia Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 101. Saudi Arabia Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. UAE Surgical Hemostatic Agents Sales Growth Rate (2016-2021) (K Units) Figure 103. UAE Surgical Hemostatic Agents Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. Surgical Hemostatic Agents Value Chain Figure 105. Channels of Distribution Figure 106. Distributors Profiles Figure 107. Bottom-up and Top-down Approaches for This Report Figure 108. Data Triangulation Figure 109. Key Executives Interviewed

J&J Baxter BD Gelita Pfizer B Braun CSL Behring Ferrosan Medical Devices Advance Medical Solution Medtronic Z-Medica Marine Polymer Equimedical CryoLife